Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance
Alexander M. Scherbakov(Gause Institute of New Antibiotics Russian Academy of Medical Sciences), Krasil'nikov Ma(Endocrinology Research Center)
Cited by 18
Related Papers
Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells
|Frontiers in Pharmacology|2018|65
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
|IUBMB Life|2016|60
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells
|Investigational New Drugs|2023|29
Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin
|Research in Pharmaceutical Sciences|2023|10